# A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

> **NCT00938262** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 24 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Fimasartan, Ketoconazole, Rifampicin

## Key facts

- **NCT ID:** NCT00938262
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2009-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938262, "A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00938262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*